Best GLP-1 Programs for Women: What to Know Before You Start

Women represent the majority of GLP-1 telehealth patients — and for good reason. GLP-1 medications like semaglutide and tirzepatide are highly effective for the hormonal weight patterns many women experience, including weight gain during perimenopause, insulin resistance related to PCOS, and the “last 20 pounds” that resist diet and exercise alone.

But not all GLP-1 programs are equally well-suited for women’s specific needs. Here’s what to look for — and which programs stand out.

Why GLP-1 Medications Work Particularly Well for Many Women

Several factors make GLP-1 treatment especially effective for women:

• Insulin resistance — Common in women with PCOS and in the perimenopausal transition; GLP-1s directly improve insulin sensitivity
• Hormonal weight gain — Estrogen fluctuations during perimenopause shift fat distribution toward the abdomen; semaglutide targets visceral fat specifically
• Food noise — Women are disproportionately affected by intrusive thoughts about food and emotionally driven eating patterns; GLP-1s quiet this significantly
• Prior diet failure — Decades of dieting often leads to metabolic adaptation that resists further restriction; GLP-1s work through a different mechanism that bypasses this

Women-Specific Considerations Before Starting a GLP-1 Program

Pregnancy and Breastfeeding

GLP-1 medications are contraindicated during pregnancy and breastfeeding. Women who are pregnant, trying to conceive, or nursing should not take semaglutide or tirzepatide. All reputable GLP-1 providers screen for this during intake. If your reproductive status changes, notify your provider immediately to pause treatment.

Hormonal Contraception

Semaglutide and tirzepatide can reduce the absorption of oral contraceptives due to their effects on gastric emptying. Women taking oral birth control pills should discuss this with their provider. Using a barrier method as backup contraception for the first 4 weeks after starting GLP-1 treatment (and after each dose increase) is commonly recommended.

PCOS

GLP-1 medications are particularly beneficial for women with PCOS. They address insulin resistance (a core driver of PCOS), reduce androgen levels, promote weight loss, and can help restore regular menstrual cycles in some patients. Several studies specifically in PCOS populations show strong outcomes. See our dedicated guide: Semaglutide for PCOS: What to Expect.

Perimenopause and Menopause

Perimenopausal weight gain — particularly increased visceral fat around the abdomen — is one area where GLP-1 medications show strong results. Declining estrogen during perimenopause contributes to insulin resistance, which GLP-1s directly counter. Many women in their 40s and 50s find that semaglutide or tirzepatide works when nothing else has post-40.

Best GLP-1 Programs for Women in 2026

1. Found Health — Best Overall for Women (~$99/mo)

Found stands out for women because of their comprehensive medication approach: they can prescribe not just GLP-1s but also metformin (which directly addresses insulin resistance in PCOS), as well as combination protocols. Their coaching app also addresses the behavioral and emotional eating patterns that disproportionately affect women.

Found accepts insurance and starts at ~$99/month. For women with PCOS or insulin resistance, their ability to prescribe multiple medications together is a significant clinical advantage.

→ Full Found Health review | Visit Found →

2. Mochi Health — Best for Women Who Want Specialist Care (~$129/mo + meds)

Mochi’s board-certified obesity medicine physicians are better equipped than general practitioners to manage the complex interplay of hormones, weight, and metabolic health in women. For perimenopausal women or those with multiple comorbidities, Mochi’s specialist-level care is genuinely different from what most GLP-1 platforms provide.

→ Full Mochi Health review | Visit Mochi →

3. Eden — Best for First-Time GLP-1 Users (~$149/mo)

Eden’s attentive care team model is particularly valuable for women new to injectable medications who want hand-holding through the titration process. Regular check-ins and responsive support make the first 90 days — when side effects and dosing questions peak — significantly smoother.

→ Full Eden review | Visit Eden →

4. Ro Body — For Women Who Want Tirzepatide Access (~$145+/mo)

Tirzepatide (Zepbound) consistently outperforms semaglutide in clinical trials, with average weight loss of 20–22% vs 15% for semaglutide. For women who are significantly overweight or haven’t responded well to semaglutide, tirzepatide through Ro is worth considering.

→ Full Ro Body review | Visit Ro →

What Results Can Women Expect on GLP-1 Medications?

In the STEP clinical trials, women consistently achieved strong results on semaglutide, averaging 14–16% body weight loss at the full 2.4mg dose. In the SURMOUNT trials for tirzepatide, women averaged 21–23% body weight loss — among the highest ever recorded in a weight loss drug trial.

Real-world results vary, but several patterns emerge specifically in women:

• Women with PCOS often see both weight loss and hormonal improvements (reduced androgens, more regular cycles)
• Perimenopausal women who have struggled to lose weight for years often report semaglutide as the first thing that has meaningfully worked
• Women who combine GLP-1 treatment with resistance training preserve muscle mass better and achieve better body composition outcomes

Tips for Women Starting GLP-1 Treatment

• Tell your provider about all hormonal medications — including birth control, HRT, and thyroid medications
• Add resistance training early — GLP-1s reduce appetite strongly, which can lead to muscle loss if protein intake and exercise aren’t maintained
• Prioritize protein — Aim for 100–130g daily to preserve lean mass during active weight loss
• Monitor hormonal changes — Significant weight loss can affect estrogen levels and menstrual cycles, especially in perimenopausal women
• Use backup contraception — For the first month of GLP-1 treatment (and after dose increases) if taking oral birth control pills

Frequently Asked Questions

Is semaglutide safe for women?

Yes — semaglutide is FDA-approved for weight management in adults, including women, with a well-established safety profile from multiple large clinical trials. The main contraindications are pregnancy, breastfeeding, personal or family history of medullary thyroid carcinoma, and MEN 2 syndrome. Women on oral contraceptives should discuss potential absorption effects with their provider.

Can I take semaglutide if I have PCOS?

Yes — semaglutide is particularly beneficial for women with PCOS. It addresses insulin resistance (a core driver of PCOS), promotes weight loss, and has been shown to reduce androgen levels and improve menstrual regularity in some patients. Discuss your full hormonal picture with your prescribing provider to ensure the treatment plan is optimized for PCOS.

Can I take GLP-1 medications while on birth control?

GLP-1 medications can reduce the absorption of oral contraceptives. Women on the pill are generally advised to use a backup contraception method for the first 4 weeks of GLP-1 treatment and after each dose increase. IUDs, patches, and injections are unaffected. Discuss your specific contraception with your provider.

Does semaglutide work for menopause weight gain?

Yes — GLP-1 medications are effective for perimenopausal and menopausal weight gain, particularly the visceral abdominal fat accumulation that becomes more pronounced as estrogen declines. Many women in their 40s and 50s report semaglutide working when diet and exercise alone have not produced results in years.

What is the best GLP-1 program for women?

Found Health is our top overall pick for women: it offers the lowest price (~$99/mo), accepts insurance, prescribes multiple medications including metformin for insulin resistance, and includes behavioral coaching. For women with complex hormonal situations or significant comorbidities, Mochi Health’s obesity medicine specialists provide a higher level of specialized care.